Back to JENNISON ASSOCIATES LLC JENNISON ASSOCIATES LLC

ARQTARQT
Showing 8 of 16 quarters

Position history for JENNISON ASSOCIATES LLCJENNISON ASSOCIATES LLC's holdings in ARCUTIS BIOTHERAPEUTICS INC

JENNISON ASSOCIATES LLC holds 5M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $117.3M as of 2026-Q1. The position was decreased (-26.3% shares). ARQT represents 0.1% of JENNISON ASSOCIATES LLC's portfolio.

Current Value

$117.3M

Current Shares

5M

Total Value Change

+$9.7M

Total Shares Change

-6.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
5M
-26.3%
$117.3M0.1%$23.60
0
2025-Q4
Decreased
6.8M
-44.9%
$196.3M0.1%$28.08
0
2025-Q3
Increased
12.3M
+10.3%
$231M0.1%$18.62
41
2025-Q2
Decreased
11.1M
-2.2%
$155.8M0.1%$13.74
0
2025-Q1
Decreased
11.4M
-7.9%
$177.7M0.1%$15.73
0
2024-Q4
Increased
12.3M
+5.8%
$171.9M0.1%$14.20
39
2024-Q3
Increased
11.7M
+0.8%
$108.5M0.1%$9.36
30
2024-Q2
Decreased
11.6M
-5.0%
$107.6M0.1%$9.30
0

Other major holders of ARQT: BlackRock, Inc., VANGUARD GROUP INC, Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used